Back to Search Start Over

109O Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2.

Authors :
Barlesi, F
Drilon, A
Braud, F De
Cho, B C
Ahn, M J
Siena, S
Krebs, M G
Lin, C C
John, T
Tan, D S W
Seto, T
Dziadziuszko, R
Arkenau, H-T
Rolfo, C
Wolf, J
Ye, C
Riehl, T
Eng, S
Doebele, R C
Source :
Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p. 1 Chart.
Publication Year :
2019

Subjects

Subjects :
*NON-small-cell lung carcinoma

Details

Language :
English
ISSN :
09237534
Volume :
30
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
136076481
Full Text :
https://doi.org/10.1093/annonc/mdz243
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details